|
| [10] | J. Bednarsch, Z. Czigany, L. R. Heij, T. Luedde, R. van Dam, S. A. Lang, T. F. Ulmer, M. W. Hornef, U. P. Neumann,
"Bacterial bile duct colonization in perihilar cholangiocarcinoma and its clinical significance", Sci. Rep., vol. 11, no. 1, pp. 2926.
|
| [9] | J. Bednarsch, Z. Czigany, S. H. Loosen, L. Heij, L. Ruckgaber, H. Maes, J. Krause, M. Reen, B. Toteva, T. Vosdellen, P. Bruners, S. A. Lang, T. F. Ulmer, C. Roderburg, T. Luedde, U. P. Neumann,
"Perioperative rifaximin is not associated with enhanced functional and volumetric recovery after major liver resection", Sci. Rep., vol. 11, no. 1, pp. 17936.
|
| [8] | M. Berres, C. Trautwein, M. Schmeding, D. Eurich, F. Tacke, M. Bahra, P. Neuhaus, U. P. Neumann, H. E. Wasmuth,
"Serum chemokine CXC ligand 10 (CXCL10) predicts fibrosis progression after liver transplantation for hepatitis C infection", Hepatology, vol. 53, no. 2, pp. 596–603.
|
| [7] | T. M. Lodewick, A. A. Roeth, S. W. Olde Damink, P. H. Alizai, R. M. van Dam, N. Gassler, M. Schneider, S. A. Dello, M. Schmeding, C. H. Dejong, U. P. Neumann,
"Sarcopenia, obesity and sarcopenic obesity: Effects on liver function and volume in patients scheduled for major liver resection", J. Cachexia Sarcopenia Muscle, vol. 6, no. 2, pp. 155–163.
|
| [6] | S. H. Loosen, C. Roderburg, K. L. Kauertz, I. Pombeiro, C. Leyh, F. Benz, M. Vucur, T. Longerich, A. Koch, T. Braunschweig, T. F. Ulmer, C. Heidenhain, F. Tacke, M. Binnebösel, M. Schmeding, C. Trautwein, U. P. Neumann, T. Luedde,
"Elevated levels of circulating osteopontin are associated with a poor survival after resection of cholangiocarcinoma", J. Hepatol., vol. 67, no. 4, pp. 749–757.
|
| [5] | D. P. Modest, T. Denecke, J. Pratschke, I. Ricard, H. Lang, M. Bemelmans, T. Becker, M. Rentsch, D. Seehofer, C. J. Bruns, B. Gebauer, H. I. Modest, S. Held, G. Folprecht, V. Heinemann, U. P. Neumann,
"Surgical treatment options following chemotherapy plus cetuximab or bevacizumab in metastatic colorectal cancer-central evaluation of FIRE-3", Eur. J. Cancer, vol. 88, pp. 77–86.
|
| [4] | U. P. Neumann, T. Berg, M. Bahra, D. Seehofer, J. M. Langrehr, R. Neuhaus, C. Radke, P. Neuhaus,
"Fibrosis progression after liver transplantation in patients with recurrent hepatitis C", J. Hepatol., vol. 41, no. 5, pp. 830–836.
|
| [3] | U. P. Neumann, A. Thelen, C. Röcken, D. Seehofer, M. Bahra, H. Riess, S. Jonas, M. Schmeding, J. Pratschke, R. Bova, P. Neuhaus,
"Nonresponse to pre-operative chemotherapy does not preclude long-term survival after liver resection in patients with colorectal liver metastases", Surgery, vol. 146, no. 1, pp. 52–59.
|
| [2] | A. A. Roeth, I. Slabu, M. Baumann, P. H. Alizai, M. Schmeding, G. Guentherodt, T. Schmitz-Rode, U. P. Neumann,
"Establishment of a biophysical model to optimize endoscopic targeting of magnetic nanoparticles for cancer treatment", Int. J. Nanomed., vol. Volume 12, pp. 5933–5940.
|
| [1] | A. Schneider, J. Gautheron, M. Feoktistova, C. Roderburg, S. Loosen, P. Schemmer, M. Büchler, U. Neumann, F. Tacke, C. Trautwein, T. Longerich, M. Vucur, T. Luedde,
"RIPK1 suppresses a TRAF2-dependent pathway to liver cancer", J. Hepatol., vol. 66, no. 1, pp. S229.
|